The translational potential of this new knowledge is exemplified by our demonstration that HDAC inhibitors can block HIV infection at the pre‐integration stage through activation of SAMHD1, thereby protecting these critical immune cells. This evidence concerns the gene HDAC9 and HIV infectious disease.